ADMP - Adamis Pharmaceuticals selling portion of compounding business for $15M
Adamis Pharmaceuticals Corp (ADMP -2.8%) is selling a significant portion of its subsidiary, US Compounding, for up to $15M before fees and expenses. The payment will be made to Adamis in monthly installments over a year based on a multiple of gross revenue generated by the assets during the measurement period. The buyer has not been named. Adamis said the transaction aligns with its goal of focusing on its prescription drugs pipeline.
For further details see:
Adamis Pharmaceuticals selling portion of compounding business for $15M